OMRON (6645) Q1 2026 earnings summary

Executive summary

• Consolidated revenue and profit increased year-over-year, overcoming cost increases from U.S. tariff policies, with strong performance in Industrial Automation and Devices & Module Solutions offsetting Healthcare declines.

• Net sales rose 3.1% year-over-year to ¥189.5bn, driven by IAB and DMB segments.

• Operating income was flat at ¥6.4bn, as higher sales and cost improvements balanced tariff impacts and development investments.

• Net income attributable to shareholders rebounded to ¥6.8bn from a loss of ¥9.6bn a year ago, reflecting the absence of prior one-time restructuring costs.

• Uncertainty persists for Q2 and beyond, mainly due to ongoing U.S. tariff policy impacts.

Financial highlights

• Q1 FY2025 net sales rose 3.1% year-over-year to ¥189.5bn; operating income up 1.7% to ¥6.4bn.

• Net income per share was ¥34.62, compared to a loss of ¥48.89 per share in the prior year.

• Gross profit margin declined from 45.4% to 43.9% due to tariff impacts and increased R&D investment.

• Comprehensive income dropped 72.8% year-over-year to ¥4.6bn.

• Net income attributable to shareholders swung from -¥9.6bn to ¥6.8bn year-over-year.

Outlook and guidance

• Full-year FY2025 forecasts remain unchanged due to continued uncertainty around U.S. tariffs.

• Net sales forecasted at ¥820.0–835.0bn (+2.3% to +4.1% year-over-year); operating income at ¥56.0–65.0bn (+3.6% to +20.3%).

• Net income expected to rise sharply to ¥29.0–35.5bn; EPS projected at ¥147.29–180.30.

• Exchange rate assumptions for Q2 and beyond: USD/JPY 140.0, EUR/JPY 160.0, CNY/JPY 20.0.